Journal of Gastroenterology

Article	Citations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	249
Reply to the letter by Huo et al. regarding our manuscript “The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan”	219
Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation	153
MAFLD: an optimal framework for understanding liver cancer phenotypes	124
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	90
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	77
Computer-aided demarcation of early gastric cancer: a pilot comparative study with endoscopists	62
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	59
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	56
Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis	50
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	47
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	42
Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials	40
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	39
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	38
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma	37
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database	37
Assessing the side effects and resistance in H. pylori treatment: a discussion on minocycline versus tetracycline therapy	37
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	35
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	35
Non-invasive early detection on esophageal squamous cell carcinoma and precancerous lesions by microbial biomarkers combining epidemiological factors in China	34
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	34
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	33
Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	31
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	31

The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	31
A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion	29
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	29
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	29
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	26
Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation	24
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	24
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	24
Response to the letter by Buldukoglu et al. regarding our manuscript “Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-	23
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	23
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	23
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study	22
Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations	22
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	22
WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway	22
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation	21
The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis	21
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors	20
Utility of a new automated diagnostic program in high-resolution esophageal manometry	19
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy	18
Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis	18
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis	18
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts	17
Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity	17
Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B	17
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	17
The useful predictors of zinc deficiency for the management of chronic liver disease	16
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	16
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation	16
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	16
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells	16
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY	15
Renal manifestations in inflammatory bowel disease: a systematic review	15
Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy	15
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	15
The first comprehensive genomic characterization of rectal squamous cell carcinoma	14
The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention	14
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	14
Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission	14
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	14
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	14
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation	14
LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	13
Multistage deep learning for classification of Helicobacter pylori infection status using endoscopic images	13
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	13
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	13
A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials	13
Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel	13
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	13
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	13

Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	13
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	13
Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes	12
Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous superficial esophageal squamous cell carcinoma	12
Acknowledgements	12
Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease	12
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents	12
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	12
Standard technique in Japan for measuring hepatic venous pressure gradient	11
Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas	11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	11
Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease	11
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation	11
Lactobacillus stress protein GroEL prevents colonic inflammation	11
Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases	11
Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.	11
STING and liver disease	10
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery	10
Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study)	10
Evidence-based clinical practice guidelines for chronic pancreatitis 2021	10
Immune therapies against chronic hepatitis B	10
Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type	10
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan	10
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver	10
Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	10
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT	10
The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors	10
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	10
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients	10
Clinical practice guidelines for duodenal cancer 2021	9
Robust automated prediction of the revised Vienna Classification in colonoscopy using deep learning: development and initial external validation	9
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	9
A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis	9
Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives	9
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	8
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	8
Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study	8
The clonal heterogeneity of colon cancer with liver metastases	8
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	8
Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019	8
Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment	8
Current status of molecular diagnostic approaches using liquid biopsy	8
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	8
Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan	8
Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?	8
Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study	8
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT	8
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	8
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	8
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	7
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	7
The association between phosphate level at admission and early mortality in acute pancreatitis	7
Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan	7
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	7
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction	7
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	7
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	7
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	7
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	7
Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients	7
Role of combined aerobic and resistance exercise in liver cirrhosis	7
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	6
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	6
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	6
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses	6
Arginase 2 attenuates ulcerative colitis by antioxidant effects of spermidine	6
Association of circulating cytokine levels and tissue-infiltrating myeloid cells with achalasia: results from Mendelian randomization and validation through clinical characteristics and single-cell RN	6
Small extracellular vesicles derived from adipose mesenchymal stem cells alleviate intestinal fibrosis by inhibiting the FAK/Akt signaling pathway via MFGE8	6
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	6
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	6
Promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy	6
The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma	6
MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents	6
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	6
Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study	6
Publisher Correction: Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	5
Conditional deletion of IP3R1 by Islet1-Cre in mice reveals a critical role of IP3R1 in interstitial cells of Cajal in regulating GI motility	5
Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study	5
Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B	5
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	5

Acknowledgements	5
Acknowledgements	5
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	5
Correction to: The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis	5
Aldh2 and the tumor suppressor Trp53 play important roles in alcohol-induced squamous field cancerization	5
Single-cell RNA sequencing and functional analysis reveal the role of altered glycosylation levels of hepatic macrophages in liver cirrhosis	5
Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting	5
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020	5
Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD	5
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	5
Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer	5
Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms	5
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	5
Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”	5
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	4
Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bil	4
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan	4
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	4
Current status of type 1 (IgG4-related) autoimmune pancreatitis	4
Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation	4
Alteration of protein expression and spliceosome pathway activity during Barrett’s carcinogenesis	4
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	4
Acknowledgements	4
Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	4
Novel probiotic yeast from Miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice	4
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	4
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	4
Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease	4
Correction to: Features of the gut prokaryotic virome of Japanese patients with Crohn’s disease	4
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway	4
Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020	4
A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding	4
Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma	4
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study	4
Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma	4
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach	4
Reply: Need for evidence on surveillance endoscopy in achalasia-related Barret esophagus and adenocarcinoma in Asian population	4
Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis	4
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum	4
Allograft liver failure awaiting liver transplantation in Japan	4
Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma	4
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer	4
Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer	4
Evidence-based clinical practice guidelines for functional dyspepsia 2021	4
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	4
Microinflammation in the intestinal mucosa and symptoms of irritable bowel syndrome	4
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	3
Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia	3
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	3
Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan	3
Gastric intestinal metaplasia: progress and remaining challenges	3
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma	3
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	3
Impact of mindfulness tendency and physical activity on brain-gut interactions	3
Risk of pneumonia associated with proton pump inhibitor use	3
Medical costs according to the stages of colorectal cancer: an analysis of health insurance claims in Hachioji, Japan	3
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	3
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	3
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	3
Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer scre	3
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	3
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	3
Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn’s disease in Japan (SPREAD-J study)	3
A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the National Cancer Database	3
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	3
Preoperative mechanical bowel preparation using conventional versus hyperosmolar polyethylene glycol-electrolyte lavage solution before laparoscopic resection for colorectal cancer (TLUMP test): a pha	3
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	3
Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis	3
Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation	3
Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma	2
Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States	2
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA	2
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime	2
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	2
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021	2
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	2
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	2
The antiferroptotic effect of indigo on ulcerative colitis	2
VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization	2
Reply to “Severe ulcerative colitis: diagnostic criteria and therapy”	2
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	2
ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis	2
Cancer risk by length of Barrett’s esophagus in Japanese population: a nationwide multicenter retrospective cohort study	2
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	2
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	2
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria	2
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	2
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	2
Analysis of the development of gastric cancer after resecting colorectal lesions using large-scale health insurance claims data	2
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	2
Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	2
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	2
Changing patterns of etiology and management of hepatocellular carcinoma: need for global reappraisal	2
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	2
Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern	2